103 related articles for article (PubMed ID: 27608954)
41. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.
He Z; Liu S; Guo M; Mao J; Hughson MD
Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424
[TBL] [Abstract][Full Text] [Related]
42. Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia.
Kunze R; Zhou W; Veltkamp R; Wielockx B; Breier G; Marti HH
Stroke; 2012 Oct; 43(10):2748-56. PubMed ID: 22933585
[TBL] [Abstract][Full Text] [Related]
43. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
Tanimoto K; Makino Y; Pereira T; Poellinger L
EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113
[TBL] [Abstract][Full Text] [Related]
44. Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression.
Périgny M; Hammel P; Corcos O; Larochelle O; Giraud S; Richard S; Sauvanet A; Belghiti J; Ruszniewski P; Bedossa P; Couvelard A
Am J Surg Pathol; 2009 May; 33(5):739-48. PubMed ID: 19238077
[TBL] [Abstract][Full Text] [Related]
45. Pharmacologic stabilization of hypoxia-inducible transcription factors protects developing mouse brain from hypoxia-induced apoptotic cell death.
Trollmann R; Richter M; Jung S; Walkinshaw G; Brackmann F
Neuroscience; 2014 Oct; 278():327-42. PubMed ID: 25162122
[TBL] [Abstract][Full Text] [Related]
46. Oncotropic H-1 parvovirus infection degrades HIF-1α protein in human pancreatic cancer cells independently of VHL and RACK1.
Cho IR; Kaowinn S; Moon J; Soh J; Kang HY; Jung CR; Oh S; Song H; Koh SS; Chung YH
Int J Oncol; 2015 May; 46(5):2076-82. PubMed ID: 25760590
[TBL] [Abstract][Full Text] [Related]
47. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
[TBL] [Abstract][Full Text] [Related]
48. Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression.
Chen LN; Wang Y; Ma DL; Chen YY
Apoptosis; 2006 Jan; 11(1):101-11. PubMed ID: 16374546
[TBL] [Abstract][Full Text] [Related]
49. [Expression of VHL and HIF-1alpha and its clinical significance in the lung cancer tissue].
Peng Z; Shan C; Wang H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 34(4):331-4. PubMed ID: 19411751
[TBL] [Abstract][Full Text] [Related]
50. Molecular basis for the regulation of hypoxia-inducible factor-1α levels by 2-deoxy-D-ribose.
Ikeda R; Tabata S; Tajitsu Y; Nishizawa Y; Minami K; Furukawa T; Yamamoto M; Shinsato Y; Akiyama S; Yamada K; Takeda Y
Oncol Rep; 2013 Sep; 30(3):1444-8. PubMed ID: 23807085
[TBL] [Abstract][Full Text] [Related]
51. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein.
Yu F; White SB; Zhao Q; Lee FS
Cancer Res; 2001 May; 61(10):4136-42. PubMed ID: 11358837
[TBL] [Abstract][Full Text] [Related]
52. Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo.
Yin A; Jiang Y; Zhang X; Zhao J; Luo H
Eur J Pharmacol; 2010 Dec; 649(1-3):120-6. PubMed ID: 20869960
[TBL] [Abstract][Full Text] [Related]
53. VHL and PTEN loss coordinate to promote mouse liver vascular lesions.
Chen S; Sanford CA; Sun J; Choi V; Van Dyke T; Samulski RJ; Rathmell WK
Angiogenesis; 2010 Mar; 13(1):59-69. PubMed ID: 20221685
[TBL] [Abstract][Full Text] [Related]
54. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
[TBL] [Abstract][Full Text] [Related]
55. DNAJB1 destabilizes PDCD5 to suppress p53-mediated apoptosis.
Cui X; Choi HK; Choi YS; Park SY; Sung GJ; Lee YH; Lee J; Jun WJ; Kim K; Choi KC; Yoon HG
Cancer Lett; 2015 Feb; 357(1):307-315. PubMed ID: 25444898
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathological Significance of Decreased Expression of the Tumor Inhibitor Gene
Gao F; Zhao M; Huang S; Zhang W; Ma Z
Genet Test Mol Biomarkers; 2019 Nov; 23(11):807-814. PubMed ID: 31638427
[No Abstract] [Full Text] [Related]
57. Involvement of autophagy in cardiac remodeling in transgenic mice with cardiac specific over-expression of human programmed cell death 5.
An L; Zhao X; Wu J; Jia J; Zou Y; Guo X; He L; Zhu H
PLoS One; 2012; 7(1):e30097. PubMed ID: 22253891
[TBL] [Abstract][Full Text] [Related]
58. Characterisation of a novel transcript LNPPS acting as tumour suppressor in bladder cancer via PDCD5-mediated p53 degradation blockage.
Li J; Wang Y; Zhang X; Yang X; Qi Q; Mi Q; Feng M; Wang Y; Wang C; Li P; Du L
Clin Transl Med; 2023 Jan; 13(1):e1149. PubMed ID: 36578176
[TBL] [Abstract][Full Text] [Related]
59. [Characterization of programmed cell death 5 (PDCD5) gene in human cartilage and its possible significance].
Cheng A; Wang Y; Ma D; Zhou H; Lou S
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 35(5):481-4. PubMed ID: 14601303
[TBL] [Abstract][Full Text] [Related]
60. Programmed cell death 5 improves skeletal muscle insulin resistance by inhibiting IRS-1 ubiquitination through stabilization of MDM2.
Li B; Ye J; Liu R; Weng L; Cao Y; Jia S; Xu C; Liu Y; Yan S; Zheng M
Life Sci; 2021 Nov; 285():119918. PubMed ID: 34480939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
